Sterling Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Sterling Capital Management's AMPH Position: Q3 2026 in Review
Sterling Capital Management increased its Amphastar Pharmaceuticals (AMPH) stake by 30% in Q3 2026, buying an estimated $63.5K and bringing the position to 12,849 shares worth $332K. The position accounts for 0.01% of the portfolio, ranked #898.
Sterling Capital Management first reported a position in AMPH in Q3 2024 and has held it in 9 quarters since. The position peaked at $452K in Q3 2024. 180 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.
- Sterling Capital Management held 12,849 shares of Amphastar Pharmaceuticals worth $332K as of Q3 2026.
- Sterling Capital Management bought 2,937 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $63.5K.
- Amphastar Pharmaceuticals made up 0.01% of Sterling Capital Management's portfolio in Q3 2026, its #898 holding.
- Sterling Capital Management first reported a position in Amphastar Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
- Sterling Capital Management's Amphastar Pharmaceuticals position peaked at $452K in Q3 2024.
- 180 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.
Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.